These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22826000)

  • 41. Recent advances in Clostridium difficile-associated disease.
    Monaghan T; Boswell T; Mahida YR
    Gut; 2008 Jun; 57(6):850-60. PubMed ID: 18252748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection.
    Cheng AC; Ferguson JK; Richards MJ; Robson JM; Gilbert GL; McGregor A; Roberts S; Korman TM; Riley TV;
    Med J Aust; 2011 Apr; 194(7):353-8. PubMed ID: 21470086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recurrent Clostridium difficile infection.
    Gribbins A
    Adv NPs PAs; 2013 Aug; 4(8):13-6; quiz 17. PubMed ID: 23943969
    [No Abstract]   [Full Text] [Related]  

  • 44. Severe infection with Clostridium difficile PCR ribotype 027 acquired in Melbourne, Australia.
    Richards M; Knox J; Elliott B; Mackin K; Lyras D; Waring LJ; Riley TV
    Med J Aust; 2011 Apr; 194(7):369-71. PubMed ID: 21470090
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clostridium difficile epidemic strain far reaching.
    Quirk M
    Lancet Infect Dis; 2006 Feb; 6(2):74. PubMed ID: 16456988
    [No Abstract]   [Full Text] [Related]  

  • 46. Clostridium difficile infection in outpatients, Maryland and Connecticut, USA, 2002-2007.
    Hirshon JM; Thompson AD; Limbago B; McDonald LC; Bonkosky M; Heimer R; Meek J; Mai V; Braden C
    Emerg Infect Dis; 2011 Oct; 17(10):1946-9. PubMed ID: 22000379
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New views on Clostridium difficile infections: Introduction.
    Rodloff A; Gould I
    Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S1. PubMed ID: 19303561
    [No Abstract]   [Full Text] [Related]  

  • 48. Community-acquired Clostridium difficile-associated diarrhea, Montréal, 2005-2006: frequency estimates and their validity.
    Allard R; Dascal A; Camara B; Létourneau J; Valiquette L
    Infect Control Hosp Epidemiol; 2011 Oct; 32(10):1032-4. PubMed ID: 21931255
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population.
    Mezoff E; Mann EA; Hart KW; Lindsell CJ; Cohen MB
    J Pediatr Gastroenterol Nutr; 2011 Apr; 52(4):437-41. PubMed ID: 21407116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
    Labbé AC; Poirier L; Maccannell D; Louie T; Savoie M; Béliveau C; Laverdière M; Pépin J
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3180-7. PubMed ID: 18573937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clostridium difficile: an update.
    Gonenne J; Pardi DS
    Compr Ther; 2004; 30(3):134-40. PubMed ID: 15793312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Diagnostics and therapy of chronic diarrhea in elderly people].
    Madisch A
    MMW Fortschr Med; 2008 Nov; 150(46):28-31; quiz 32. PubMed ID: 19130728
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clostridium difficile infection as interdisciplinary challenge. Current discussions in respect to epidemiology, diagnostic methods, risk classification as well as treatment options].
    Lipp HP
    Med Monatsschr Pharm; 2013 Feb; 36(2):53-62; quiz 63-4. PubMed ID: 23451705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyperimmune yolk extract with Immunoglobulin Y basic active principle as a possible adjuvant treatment in patients who need/benefit from neurorehabilitation, with
    Mandu M; Onose G
    J Med Life; 2022 Feb; 15(2):162-167. PubMed ID: 35419106
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The situation and management of Clostridium difficile infection in Spain: an opinion document.
    Bouza E; Marín M; Peláez T; Alcalá L;
    Rev Esp Quimioter; 2013 Sep; 26(3):261-86. PubMed ID: 24080894
    [No Abstract]   [Full Text] [Related]  

  • 56. Clostridium difficile-associated infection: a disease of varying severity.
    Jawa RS; Mercer DW
    Am J Surg; 2012 Dec; 204(6):836-42. PubMed ID: 23036604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of administrative data for evaluating the shifting acquisition of Clostridium difficile infection in England.
    Jen MH; Saxena S; Bottle A; Pollok R; Holmes A; Aylin P
    J Hosp Infect; 2012 Mar; 80(3):229-37. PubMed ID: 22306443
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diarrhea With Clostridium difficile-Positive Stool-Trick or Treat: A Teachable Moment.
    Matta SK; Greenberg A; Singh A
    JAMA Intern Med; 2015 Nov; 175(11):1746-7. PubMed ID: 26368062
    [No Abstract]   [Full Text] [Related]  

  • 59. Clostridium difficile infection--not just a burden anymore.
    Bulik CC; Kuti JL; Nicolau DP
    Conn Med; 2009 Aug; 73(7):407-11. PubMed ID: 19708320
    [No Abstract]   [Full Text] [Related]  

  • 60. Impact of different empirical antibiotic treatment regimens for community-acquired pneumonia on the emergence of Clostridium difficile.
    Bruns AH; Oosterheert JJ; Kuijper EJ; Lammers JW; Thijsen S; Troelstra A; Hoepelman AI
    J Antimicrob Chemother; 2010 Nov; 65(11):2464-71. PubMed ID: 20823105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.